Sera Prognostics is a leading proteomic and bioinformatics company dedicated to improving the lives of women and babies through precision biomarker-based tests designed to enhance pregnancy care. Sera’s vision is to deliver pivotal information in early pregnancy to physicians, to help them to improve the health of their patients and reduce costs of healthcare delivery.

Biotechnology

Sera Prognostics

Evguenia Lindgardt

Austin Aerts

Steve Borst

Nichole Martin

Doug Roach

Douglas Fisher

Michael R. Foley

Paul Kearney

Benjamin G. Jackson

Robert G. Harrison

Jay Boniface

The executive team at Sera Prognostics has a long history of experience in the pharmaceutical industry, with members coming from companies such as Myrexis, Inc., Prolexys Pharmaceuticals, and Eos Biotechnology. They also have a strong educational background, with degrees from institutions such as Albany Medical College and Stanford University School of Medicine.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Sera Prognostics

Leadership Team

Board of Directors